Tonix Pharm Hldg (TNXP) Misses Q2 EPS by 8c

Tonix Pharm Hldg (NASDAQ: TNXP) reported Q2 EPS of ($0.61), $0.08 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Tonix Pharm Hldg (TNXP) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Middleby board approves spin-off of food processing unit Midera
• OfferUp Honors Small Businesses by Spotlighting Entrepreneurs Who Built Their Companies Using the Platform